Latest News
Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. Estimates – NYSE:BIO
- Form 4 BIO-RAD LABORATORIES: Sedat Evran (EVP, Global Supply Chain) For: 20 October
- Form 4 BIO-RAD LABORATORIES: Sedat Evran (EVP, Global Supply Chain) For: 20 October
- Bio-Rad Laboratories Inc (BIO) Stock Down 3.0% but Still Overval
- BIO Q3'26 Earnings: revenue estimate is 649.94M USD
- Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
- Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
- Is Bio Rad Laboratories (BIO) Fully Priced After Rising Demand In Diagnostics And Proteomics?
- Bio-Rad Laboratories Inc (BIO) Shares Fall 5.9% -- What GF Score of 73 Tells Investors
- Weekly Recap: Bio-Rad growth and margin plan and digital PCR expansion
- Bio-Rad at bernstein healthcare forum: shift toward profitable growth
- Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher
Headlines from the last 30 days, linking to the original publishers. See all market news →